Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 297

Showing 1-25 of 297 citing articles:

Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4363-4363
Open Access | Times Cited: 214
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 175
Managing the TME to improve the efficacy of cancer therapy
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 121
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 976-976
Open Access | Times Cited: 85
Chronic inflammation, cancer development and immunotherapy
Yalei Wen, Ying‐Jie Zhu, Caishi Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 84
Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 73
Innovative strategies for photodynamic therapy against hypoxic tumor
Xiaotong Li, Lei Chen, Miaoting Huang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 1, pp. 100775-100775
Open Access | Times Cited: 54
Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma
Jingjia Chang, Hao Wu, Jin Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166746-166746
Open Access | Times Cited: 44
Characterization of immune cell populations in the tumor microenvironment of colorectal cancer using high definition spatial profiling
Michelli F. Oliveira, Juan P. Romero, Meii Chung, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 36
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Rasha Babiker, et al.
Cancer Letters (2024) Vol. 591, pp. 216894-216894
Open Access | Times Cited: 33
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 22
Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer
Ana Podolski-Renić, Ana Čipak Gašparović, Andreia Valente, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116363-116363
Closed Access | Times Cited: 21
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 20
The tumor microenvironment: a key player in multidrug resistance in cancer
Lingnan Meng, Ying Zheng, Hao Liu, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 1, pp. 41-58
Open Access | Times Cited: 15
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 14
Nanocatalytic Anti‐Tumor Immune Regulation
Mingyuan Li, Han Jiang, Ping Hu, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 13
Closed Access | Times Cited: 13
Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy
Shaomin Yan, Yu Gan, Huizhe Xu, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 12
Open Access | Times Cited: 1
Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
Hanxin Liu, Huifang Zhao, Yu Sun
Seminars in Cancer Biology (2021) Vol. 86, pp. 769-781
Open Access | Times Cited: 68
The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy
Aneta Sevcikova, Nikola Izoldova, Viola Stevurkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 488-488
Open Access | Times Cited: 60
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
Lei Zhang, Biwei Ye, Zhuo Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 982-997
Open Access | Times Cited: 46
Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer
Yu Guo, Min Wang, Yongbo Zou, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 44
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer
Jindong Xie, W. H. Tian, Yuhui Tang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top